Don't miss this! Drug Target Review spoke with Dr. Mark R. Kelley, Associate Director of Basic Science at the IU Simon Comprehensive Cancer Center, and Betty and Earl Herr Professor in Pediatric Oncology Research, prior to his talk at the 2024 #PharmSci360. He discusses what makes APE1/Ref-1 a promising target for #cancertherapy.